TrialHIV medicine2014

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

C D Zorrilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.